Feb 20, 2020
Wize Pharma Completes Bonus BioGroup Strategic Transaction
Jan 16, 2020
Wize Pharma Executes Agreements for Strategic Transaction With Bonus BioGroup
Dec 03, 2019
Wize Pharma Lenders Convert $760,000 of Loans Into Equity
Sep 09, 2019
Wize Pharma Enters Exclusive License Agreement for Ophthalmic Non-viral Gene Therapy Technology
Jul 08, 2019
Wize Pharma Retains Life Science Advisory Firm Lighthouse BioPartners to Support Potential Pharma Partnership Deals for its Lead Asset LO2A
Jun 28, 2019
Wize Pharma Completes Milestone for Joint Venture With Cannabics Pharmaceuticals; Companies to Develop Cannabinoid Ophthalmic Treatments
Jun 14, 2019
Wize Pharma Interview to Air on Bloomberg International on the RedChip Money Report June 16, 2019
Apr 30, 2019
Wize Pharma to Present at ThinkEquity Conference on May 2, 2019 in New York City
Apr 24, 2019
Wize Pharma's CEO Noam Danenberg Increases Stake in Company
Apr 23, 2019
Wize Pharma Appoints Mark Sieczkarek as Chairman of the Board, Noam Danenberg to Become Chief Executive Officer
Mar 06, 2019
Wize Pharma, Inc. Closes Deal to Launch Joint Venture With Cannabics
Feb 07, 2019
Wize Pharma, Inc. Signs Joint Venture With Cannabics, to Research and Develop Cannabinoid Formulations to Treat Ophthalmic Conditions
Jan 10, 2019
Wize Pharma, Inc. Announces Publication of Peer Reviewed LOA2 Data on Treatment of Moderately Severe Sjögren's Syndrome-Related Dry Eye
Oct 24, 2018
Wize Pharma, Inc. Announces Closing of $4.45 Million Private Placement
Oct 23, 2018
Wize Pharma, Inc. Announces $4.45 Million Private Placement
Jun 05, 2018
Wize Pharma Signs Distribution Agreement in China for LO2A
Feb 28, 2018
Wize Pharma Announces Expected Exercise of Investment Rights and Warrants for Total Proceeds of $1.14 Million
Nov 16, 2017
Wize Announces Closing of Merger